Nerve excitability assessment in chemotherapy-induced neurotoxicity

Journal of Visualized Experiments

Volumn , Issue 62, 2012, Pages

  Park, Susanna B ^a,b   Lin, Cindy S Y ^b   Kiernan, Matthew C ^a,b  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

Chemotherapy; Ion channel function; Issue 62; Medicine; Nerve excitability; Neuropathy; Neuroscience; Neurotoxicity; Oncology; Oxaliplatin

Indexed keywords

EID: 84860641062     PISSN: 1940087X     EISSN: None     Source Type: Journal    
DOI: 10.3791/3439     Document Type: Article

References (13)

1. Hausheer, F.H., Schilsky, R.L., Bain, S., Berghorn, E.J., & Lieberman, F. Diagnosis, management, and evaluation of chemotherapy-induced peripheral neuropathy. Semin. Oncol. 33, 15-49 (2008).
2. Park, S.B., Krishnan, A.V., Lin, C.S., Goldstein, D., Friedlander, M., & Kiernan, M.C. Mechanisms underlying chemotherapy-induced neurotoxicity and the potential for neuroprotective strategies. Curr. Med. Chem. 15, 3081-3094 (2008).
3. Park, S.B., Lin, C.S., Krishnan, A.V., Goldstein, D., Friedlander, M.L., & Kiernan, M.C. Long-term Neuropathy after Oxaliplatin Treatment: Challenging the Dictum of Reversibility? The Oncologist. In press, (2012).
4. Postma, T.J. & Heimans, J.J. Grading of chemotherapy-induced peripheral neuropathy. Ann. Oncol. 11, 509-513 (2000).
5. Cascinu, S., Catalano, V., Cordella, L., Labianca, R., Giordani, P., Baldelli, AM., Beretta, G.D., Ubiali, E., & Catalano, G. Neuroprotective effect of reduced gluthathione on oxaliplatin-based chemotherapy in advanced colorectal cancer: a randomized, double-blind, placebo-controlled trial. J. Clin. Oncol. 20, 3478-83 (2002).
6. Lehky, T.J., Leonard, G.D., Wilson, R.H., Grem, J.L., & Floeter, M. K Oxaliplatin-induced neurotoxicity: acute hyperexcitability and chronic neuropathy. Muscle Nerve. 29, 387-392 (2004).
7. Bostock, H., Cikurel, K., & Burke, D. Threshold tracking techniques in the study of human peripheral nerve. Muscle Nerve. 21,137-158 (1998).
8. Burke, D., Kiernan, M.C., & Bostock, H. Excitability of human axons. Clin. Neurophysiol. 112, 1575-1585 (2001).
9. Krishnan, A.K., Lin, C.S., Park, S.B., & Kiernan, M.C. Axonal ion channels from bench to bedside: a translational neuroscience perspective. Prog. Neurobiol. 89, 288-313 (2009).
10. Park, S.B., Lin, C.S., Krishnan, A.V., Goldstein, D., Friedlander, M., & Kiernan, M.C. Oxaliplatin-induced neurotoxicity: changes in axonal excitability precede development of neuropathy. Brain. 132, 2712-2723 (2009).
11. Park, S.B., Goldstein, D., Lin, C.S., Krishnan, A.V., Friedlander, M.L., & Kiernan, M.C. Acute abnormalities of sensory nerve function associated wtih oxaliplatin-induced neurotoxicity. J. Clin. Oncol. 27, 1243-1249 (2009).
12. Krishnan, A.V., Goldstein, D., Friedlander, M., & Kiernan, M.C. Oxaliplatin-induced neurotoxicity and the development of neuropathy. Muscle Nerve. 32, 51-60 (2005).
13. Krishnan, A.V., Goldstein, D., Friedlander, M., & Kiernan, M.C. Oxaliplatin and axonal Na+ channel function in vivo. Clin. Cancer Res. 12, 4481-4484 (2006).